Modal Title

Modal Description

Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals
News Bird & Bird adds bench strength in Germany with two new partner hires

Dec 29 2025

Read More
Deal Bird & Bird advises the African Development Bank on €100 million financing to strengthen the cocoa sector in Ivory Coast

Dec 18 2025

Read More
Deal Bird & Bird advises ASX-listed Flight Centre Travel Group on its acquisition of Iglu

Dec 17 2025

Read More
Deal Bird & Bird advises Pathos Communications plc on its AIM IPO

Dec 17 2025

Read More
Deal Bird & Bird advises Orphalan on the acquisition of Orphelia Pharma

Dec 16 2025

Read More
Deal Bird & Bird ATMD advises SuperX on Strategic Investment in NVIDIA Solution Provider MicroInference

Dec 15 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare